## Abstract Between January 1, 1968 and December 31, 1978, 42 patients with malignant lesions involving the major salivary glands were seen at the Medical College of Virginia. A 60% 2βyear survival and a 42% 5βyear survival were noted. Histologic type was the major determinant of survival. Symptoms
Mesenchymal neoplasms of the major salivary glands: clinicopathological features of 18 cases
β Scribed by Kyung-Ja Cho; Jae Y. Ro; Jene Choi; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
- Publisher
- Springer-Verlag
- Year
- 2007
- Tongue
- English
- Weight
- 898 KB
- Volume
- 265
- Category
- Article
- ISSN
- 0302-9530
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Kaposi sarcoma (KS), one of the defining tumors of acquired immune deficiency syndrome (AIDS), is rarely identified in the major salivary glands. To the authors' knowledge, no previous published series has evaluated the clinicopathologic aspects of this tumor in major salivary gland
## Abstract ## Background. Salivary gland tumors represent 1% of head and neck tumors, with only 5% of these occurring in patients younger than 20 years. Mucoepidermoid carcinoma (MEC) is one of the most frequent salivary gland cancers among adults and children. ## Methods. This survey was condu
A 53 year-old female was referred to Geisinger Medical Center for evaluation of a large tongue base tumor. Surgical excision of the mass was performed, and was consistent with a low grade salivary gland tumor, likely a myoepithelial neoplasm. Minor salivary gland neoplasms are rare, and those arisi
Basal-cell adenoma and basal-cell adenocarcinoma of the salivary gland are rare tumors. Fine-needle aspiration cytology of these tumors, particularly those of basal-cell adenocarcinoma, has rarely been described in the literature. In this report, we describe the clinical, cytomorphologic, histopatho
## METHODS. Clinical data and 15 histopathologic features were compared in 4 patient groups based on outcome after initial treatment. The outcome groups were 1) 2 Department of Oral and Maxillofacial Patholsurvival without disease, 2) survival with tumor recurrence only, 3) survival with ogy, Nava